Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just added at .6550 to average down my .75's
The panel voted the data were insufficient to demonstrate safety (which is different from saying the vaccine was not safe, an important distinction!).
http://seekingalpha.com/article/1012961-dynavax-crashes-on-unexpected-panel-vote
It's unfortunate one or more panel members did not have the presence of mind to 'educate' their fellow panel members on trial conduct and statistical analysis (though one member did attempt to do this, as did the DVAX personnel present). That fact is, as was argued, even if the size of the populations used in the Phase 3 trial had been doubled or tripled, it was highly unlikely that events falling outside the safety envelope would have been detected.
I show 250,000
HCKI 6's getting hit should see 7's soon
Its posted on the front page of the website
http://www.indocan.com/frontpage.html
5 x .0008 on the bid 2x .0009 on the ask
looks like we have some support at .0008
Great prediction Nostradamus!!!
LMAO I don't know why you even waste your time posting that crap.
I'm still waiting on my TDA shares. At least my Schwab account got them right away.
.0023's almost gone hold here we go
A Ray Of Hope For Medivation
Medivation shares are down and out after its Alzheimer's drug Dimebon bombed in its first big trial. But the drug may not be completely dead yet, says University of Southern California Alzheimer's expert Lon Schneider.
Schneider, who generally has been skeptical of Dimebon (see this post), does point to one small ray of hope for Medivation and its partner Pfizer buried in yesterday's news release: It turned out that while Dimebon did nothing to improve the cognitive abilities of Alzheimer's patients (the primary goal of the trial), patients who took the drug did improve slightly over the course of the trial on something called the Neuropsychiatric Inventory. The improvement was not statistically significant versus the control group, however. This scale measures behavioral problems seen in patients with psychiatric and neurological disorders, including delusions, hallucinations, agitation, and anxiety.
Why does this matter? The current failed trial was in mild to moderate Alzheimer's cases. But Pfizer and Medivation are conducting two big trials in patients with moderate to severe Alzheimer's Disease, who may have more severe behavioral problems. One of these trials uses the Neuropsychiatric Inventory as its primary goal; the other has it as a secondary goal. Dr. Schneider points out that the drug Dimebon bears some chemical similarity to various antidepressants and anti-psychotic drugs that improve behavior. It could be that the drug indeed does nothing to help memory at all directly--but does help improve behavior in severely demented patients. If these two trials come out positive on the NPI, then the drug still may have a shot at getting approved. Time will tell.
http://blogs.forbes.com/sciencebiz/2010/03/a-ray-of-hope-for-medivation/?partner=yahootix
1.7 million shares were just bought at .0265
Nope I'm sitting tight. But I'm glad I picked up my extra shares yesterday.
Sorry guys I'm at work and cant bring up the L2
Same here bought in a few months back. Ended up averaging down. Now I'm nicely in the green. Just think what a PR would do right about now.
Great way to end the week. Congrats to all
Wouldn't that be a nice Christmas present!!!
Its good to see volume at a different time than the last 10 min of trading.
What a nice Friday surprise!
Just got this HEB market watch in my email.
MarketWatch News
Hemispherx Biopharma, Inc HEB:AMEX
Stocks in focus for Wednesday
MarketWatch
6:47 PM ET
SAN FRANCISCO (MarketWatch) -- Among the shares expected to see active trade in Wednesday's session are Aeropostale, Synopsys, and McDonald's. Auto stocks, led by Ford, may remain in focus amid signs that the worst is over for the industry.
Hemispherx BioPharma Inc. said late Tuesday the FDA told it two primary clinical studies submitted with its new drug application for Ampligen "did not provide credible evidence of efficacy."
230,000 just went at .024 Nice big block.
Nope that just seems like a typical Friday.
How many do you have ill take em off your hands
Now we know where support is.
at least we are getting a little volume now.
Hes a shorter he said so himself.
These things take time. Have some patience. I bought into synj a few months ago at .0006 it then fell to .0004 and .0003 and stayed there for a couple weeks before it took off and I sold it at .0048.
I added another 25k this morning :)
IHGP Huge PR! Get in before it takes off!
Interact Holdings Group Inc. Announces Discussions to Build Solar Powered Wireless Monitoring Stations
ATLANTA, July 15 /PRNewswire-FirstCall/ -- Interact Holdings Group Inc. (Pink Sheets: IHGP) announced today it has been approached to build Solar Powered Wireless Monitoring Stations.
The Solar Powered Wireless Monitoring Stations will be used in remote locations for the prospective customers to be able to monitor and access information on their remote equipment. The proposed order size is between 400 and 500 units over the course of 12-24 months. The anticipated revenue per unit is $2,500.
"With pleasure we announce that after closely working with an affiliate company, we are in the final stages of discussions to become part of an venture that will update industrial equipment monitoring stations with the latest Solar Powered Cellular Monitoring Stations. It's Interact Holdings Group's stand that we will be in the forefront of helping industry to use available technology to join the 'Green Movement!'
This is just the first step in establishing a pattern where industry will phase out its present energy hungry systems for the more Eco-Friendly Solar Powered Systems. As this trend takes hold we see this as being another Long Term Revenue Generating Asset to add to our Corporate Portfolio," stated William Yates, President of Interact Holdings Group Inc.
For more information about Interact Holdings Group Inc., visit http://www.interactholdings.com/.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Interact Holdings Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
That was me i was testing to see if there were any buying issues but apparently not. It just looks like no one is buying.